Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan;53(1):19-26.
doi: 10.1016/j.arbres.2016.07.004. Epub 2016 Aug 9.

Anti-Influenza Treatment: Drugs Currently Used and Under Development

[Article in English, Spanish]
Luciano Amarelle  1 , Emilia Lecuona  2 , Jacob I Sznajder  3
Affiliations
Review

Anti-Influenza Treatment: Drugs Currently Used and Under Development

[Article in English, Spanish]
Luciano Amarelle et al. Arch Bronconeumol. 2017 Jan.

Abstract

Influenza is a very common contagious disease that carries significant morbidity and mortality. Treatment with antiviral drugs is available, which if administered early, can reduce the risk of severe complications. However, many virus types develop resistance to those drugs, leading to a notable loss of efficacy. There has been great interest in the development of new drugs to combat this disease. A wide range of drugs has shown anti-influenza activity, but they are not yet available for use in the clinic. Many of these target viral components, which others are aimed at elements in the host cell which participate in the viral cycle. Modulating host components is a strategy which minimizes the development of resistance, since host components are not subject to the genetic variability of the virus. The main disadvantage is the risk of treatment-related side effects. The aim of this review is to describe the main pharmacological agents currently available and new drugs in the pipeline with potential benefit in the treatment of influenza.

Keywords: Drugs; Fármacos; Gripe; Influenza; Influenza virus; Tratamiento; Treatment; Virus influenza.

PubMed Disclaimer

Figures

Figura 1
Figura 1
Esquema representativo del ciclo del virus influenza A y sus sitios de acción para los antivirales actualmente utilizados y en estudio.
See this image and copyright information in PMC

References

    1. Cox N.J., Subbarao K. Influenza. Lancet. 1999;354:1277–1282. - PubMed
    1. Van Elden L.J., van Essen G.A., Boucher C.A., van Loon A.M., Nijhuis M., Schipper P. Clinical diagnosis of influenza virus infection: Evaluation of diagnostic tools in general practice. Br J Gen Pract. 2001;51:630–634. - PMC - PubMed
    1. Cao B., Li X.W., Mao Y., Wang J., Lu H.Z., Chen Y.S. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. N Engl J Med. 2009;361:2507–2517. - PubMed
    1. Jain S., Kamimoto L., Bramley A.M., Schmitz A.M., Benoit S.R., Louie J. Hospitalized patients with 2009 H1N1 influenza in the United States, april-june 2009. N Engl J Med. 2009;361:1935–1944. - PubMed
    1. World Health Organization. Influenza (seasonal). Fact sheet No 211, March 2014. Disponible en: www.who.int/mediacentre/factsheets/fs211/en/

MeSH terms